Preferential alkaline phosphatase isoenzyme induction by sodium butyrate

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• SW-620 cells, derived from human colon carcinoma, exhibit two alkaline phosphatase (AP) isoenzymes.
• Basal conditions show a predominance of the heat-stable, term-placental AP isoenzyme.
• The heat-labile, liver/bone/kidney (L/B/K) AP isoenzyme is a minor component in SW-620 cells.

Purpose of the Study:

• To investigate the effect of sodium butyrate on AP activity and isoenzyme distribution in SW-620 cells.
• To compare the effects of sodium butyrate with other known AP inducers like prednisolone and hyperosmolality.

Main Methods:

• Culturing SW-620 human colon carcinoma cells.
• Treatment of cells with sodium butyrate, prednisolone, and hyperosmotic conditions.
• Assay of alkaline phosphatase activity and analysis of isoenzyme distribution.

Main Results:

• Sodium butyrate treatment significantly increased total AP activity in SW-620 cells.
• The increased activity was exclusively due to the augmentation of the L/B/K AP isoenzyme.
• Term-placental AP isoenzyme levels remained unaffected by sodium butyrate.
• Prednisolone and hyperosmolality did not alter AP specific activity or isoenzyme profiles.

Conclusions:

• Sodium butyrate preferentially induces the L/B/K AP isoenzyme in SW-620 colon carcinoma cells.
• This induction suggests that butyrate may promote a more differentiated cellular phenotype in these cancer cells.
• The differential response highlights distinct regulatory mechanisms for AP isoenzymes in colon cancer.